Type 2 diabetes is often considered a lifelong condition, but groundbreaking research suggests that remission is possible for ...
In two new phase 3 clinical trials, the experimental GLP-1 drug also improved blood sugar, heart health metrics, and ...
Retatrutide conferred weight loss of greater than 20% for adults with obesity and type 2 diabetes, as well as those with ...